Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

Comment by Jennifer2020on Dec 25, 2020 1:10am
187 Views
Post# 32182292

RE:FLU/COVID Antigen Combo Test? - "continuously working on..."

RE:FLU/COVID Antigen Combo Test? - "continuously working on..."God Bless em for releasing the fins earlier than expected.  What a sweet gift.  Historic moment as this is probably the first qtr in MIR's history they show a net income instead of a loss.  
    They do break down income by geographic area on SEDAR MD&A great one.
God Bless Ritec AG for financing product development of possible Antigen combo test apparently, the way I read this from MD&A:


Related party transactions The following transactions occurred with related parties during the three months ended October 31, 2020: • Short term loans totalling $11,346 were repaid to employees (July 31, 2020 - $125,939) • A product development agreement worth $723,000 was received from Ritec AG (July 31, 2020 - $0)

FDA EUA for RealCovid 19 and an announcement of Antigen test and we is off to the races again in earnest, IMHO


<< Previous
Bullboard Posts
Next >>